The U.S. Food and Drug Administration has approved Takeda Pharmaceuticals Adzynma, the first recombinant protein product indicated for prophylactic or on-demand enzyme replacement therapy (ERT) in adult and pediatric patients ...
Nov 14, 2023
0
1
A new study by Hospital for Special Surgery (HSS) investigators has found that an initial high-risk antibody profile for antiphospholipid syndrome (APS) tended to remain high in pediatric patients. The results were presented ...
Nov 13, 2023
0
0
For pediatric patients with sickle cell disease (SCD), ophthalmologic complications include nonproliferative retinopathy (NPR) and proliferative retinopathy (PR), which occur in 33 and 6 percent, respectively, according to ...
Nov 9, 2023
0
0
Pediatric Emergency Department (ED) visits for firearm injuries doubled during the pandemic compared to earlier trends, according to a multicenter study published in the journal Pediatrics. During this time, deaths from firearm ...
Nov 6, 2023
0
0
The U.S. Food and Drug Administration has approved Amgen's Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable with Stelara (ustekinumab) for multiple inflammatory diseases.
Nov 3, 2023
0
1
Historically, most children in the United States who needed to be hospitalized were treated at general hospitals treating both children and adults. But the number of hospitals providing inpatient care for children has decreased ...
Oct 30, 2023
0
18
A faculty member and group of students from the University of New England College of Osteopathic Medicine (UNE COM) published a study earlier this year with findings that may help relieve pain in pediatric patients following ...
Oct 27, 2023
0
0
Cow's milk allergy is the most common type of food allergy in children—it's also the weirdest.
Oct 24, 2023
0
57
Using a simple concept and a patented Sandia sensor that detects radioactive materials, a team at Sandia National Laboratories has developed a patch to stop damage to healthy tissue during proton radiotherapy, one of the ...
Oct 23, 2023
0
1
For pediatric patients with mild-to-moderate inflammatory bowel disease, transcutaneous auricular vagus nerve stimulation (ta-VNS) attenuates signs and symptoms of disease, according to a study published online Oct. 18 in ...
Oct 20, 2023
0
0
